Application 089047
- Type
- ANDA
- Sponsor
- NOVARTIS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | SULF-15 | SULFACETAMIDE SODIUM | SOLUTION/DROPS;OPHTHALMIC | 15% | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A089047-001 | SULF-15 | SULFACETAMIDE SODIUM | 15% | SOLUTION/DROPS / OPHTHALMIC | 1995-10-31 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-09-29 23:25 UTC | 2022-09 | A089047-001 | SULF-15 | 15% | SOLUTION/DROPS / OPHTHALMIC | 1995-10-31 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A089047-001 | SULF-15 | 15% | SOLUTION/DROPS / OPHTHALMIC | 1995-10-31 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A089047-001 | SULF-15 | 15% | SOLUTION/DROPS / OPHTHALMIC | 1995-10-31 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sulfacetamide Sodium | SULFACETAMIDE SODIUM | Preferred Pharmaceuticals, Inc | cf0cc763-49b5-435d-852b-e7617c8d3286 | 2026-09-02 | Warnings, Adverse reactions | SULFACETAMIDE SODIUM |
| Sulfacetamide Sodium | SULFACETAMIDE SODIUM | A-S Medication Solutions | f212af23-be3d-4e82-9f6f-5ddce12a89da | 2026-03-23 | Warnings, Adverse reactions | SULFACETAMIDE SODIUM |
| OVACE | SULFACETAMIDE SODIUM | Mission Pharmacal Company | a77aed6c-355f-44ed-ae95-78b4d1549c2b | 2026-01-08 | Warnings, Adverse reactions | SULFACETAMIDE SODIUM |
| Sodium Sulfacetamide, Sulfur | SULFACETAMIDE SODIUM | BioComp Pharma, Inc. | ed616ece-09b5-41d5-ae58-8e016da2c6b3 | 2025-12-17 | Warnings, Adverse reactions | SULFACETAMIDE SODIUM |
| SULFACETAMIDE SODIUM | SULFACETAMIDE SODIUM | BioComp Pharma, Inc. | f79c8287-a832-4f39-ad4d-3a12d64618ab | 2025-12-17 | Warnings, Adverse reactions | SULFACETAMIDE SODIUM |
| OVACE Plus | SULFACETAMIDE SODIUM | Mission Pharmacal Company | eca5fc5d-35d0-4803-990d-1f38f860c52a | 2025-12-03 | Warnings, Adverse reactions | SULFACETAMIDE SODIUM |
| OVACE Plus | SULFACETAMIDE SODIUM | Mission Pharmacal Company | 6a034465-e600-49cb-91bd-7b9ceee6ffc6 | 2025-12-03 | Warnings, Adverse reactions | SULFACETAMIDE SODIUM |
| Ovace Plus | SULFACETAMIDE SODIUM | Mission Pharmacal Company | 073a44cd-f679-48bd-b90d-cf06f32ff07d | 2025-08-13 | Warnings, Adverse reactions | SULFACETAMIDE SODIUM |
| OvacePlus Plus | SULFACETAMIDE SODIUM | Mission Pharmacal Company | 06876575-edf2-4844-8f20-3eb6e74ccc8e | 2025-08-12 | Warnings, Adverse reactions | SULFACETAMIDE SODIUM |
| SULFACETAMIDE SODIUM | SULFACETAMIDE SODIUM | Cintex Services, LLC | 214ff8a6-179f-b907-e063-6394a90adcb1 | 2024-09-04 | Warnings, Adverse reactions | SULFACETAMIDE SODIUM |
| Sulfacetamide Sodium | SULFACETAMIDE SODIUM | NuCare Pharmaceuticals,Inc. | 9910ec80-e37c-6a83-e053-2995a90a8237 | 2024-06-20 | Warnings, Adverse reactions | SULFACETAMIDE SODIUM |
| SULFACETAMIDE SODIUM | SULFACETAMIDE SODIUM | Cintex Services, LLC | 0fa3302e-b2b4-6b9b-e063-6394a90abc2c | 2024-01-23 | Warnings, Adverse reactions | SULFACETAMIDE SODIUM |
| Sulfacetamide Sodium | SULFACETAMIDE SODIUM | Bausch & Lomb Incorporated | 6c1b2658-e756-4f31-9bc8-f99a0baa4637 | 2023-08-31 | Warnings, Adverse reactions | SULFACETAMIDE SODIUM |
| Sulfacetamide Sodium | SULFACETAMIDE SODIUM | Padagis Israel Pharmaceuticals Ltd | 4fb4d39a-330e-4c84-abbc-3b33b36b206f | 2023-04-01 | Warnings, Adverse reactions | SULFACETAMIDE SODIUM |
| Sulfacetamide Sodium | SULFACETAMIDE SODIUM | Asclemed USA, Inc. | c4c29e13-8303-4a9a-bb47-d7413eaf2f26 | 2022-10-12 | Warnings, Adverse reactions | SULFACETAMIDE SODIUM |
| Sulfacetamide Sodium | SULFACETAMIDE SODIUM | Proficient Rx LP | 2b4f125c-338e-479f-8feb-b82324230c65 | 2022-08-01 | Warnings, Adverse reactions | SULFACETAMIDE SODIUM |
| SULFACETAMIDE SODIUM | SULFACETAMIDE SODIUM | KMM Pharmaceuticals, LLC | cdb5b3dc-9f75-85b7-e053-2a95a90a380c | 2022-02-14 | Warnings, Adverse reactions | SULFACETAMIDE SODIUM |
| PLEXION NS | SULFACETAMIDE SODIUM | Eckson Labs, LLC | cdb4c921-e671-6f06-e053-2995a90abd1e | 2022-02-10 | Warnings, Adverse reactions | SULFACETAMIDE SODIUM |
| Sulfacetamide Sodium | SULFACETAMIDE SODIUM | Asclemed USA, Inc. | 129d5dd9-32a4-4398-862d-820cd4468448 | 2020-10-24 | Warnings, Adverse reactions | SULFACETAMIDE SODIUM |
| Klaron | SULFACETAMIDE SODIUM | Bausch Health US, LLC | 66ab38ea-5cea-47be-97f2-486517999fb0 | 2020-08-31 | Warnings, Adverse reactions | SULFACETAMIDE SODIUM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.